BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30451797)

  • 21. Clinicopathological Stratification and Long-term Follow-up of Patients with Periampullary Carcinomas.
    Schmuck RB; Brokat C; Andreou A; Felsenstein M; Klein F; Sinn B; Pratschke J; Bahra M
    Anticancer Res; 2018 Sep; 38(9):5379-5386. PubMed ID: 30194192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
    Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
    Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes.
    Sanada Y; Yoshida K; Konishi K; Oeda M; Ohara M; Tsutani Y
    Oncol Rep; 2006 May; 15(5):1157-61. PubMed ID: 16596179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: A retrospective multivariate analysis of a single centre experience.
    Petrou A; Soonawalla Z; Silva MA; Manzelli A; Moris D; Tabet PP; Friend P
    J BUON; 2016; 21(4):874-882. PubMed ID: 27685908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of neoadjuvant therapy on the histopathological features of pancreatic ductal adenocarcinoma - A systematic review and meta-analysis.
    Schorn S; Demir IE; Reyes CM; Saricaoglu C; Samm N; Schirren R; Tieftrunk E; Hartmann D; Friess H; Ceyhan GO
    Cancer Treat Rev; 2017 Apr; 55():96-106. PubMed ID: 28342938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K; Meyer F; Schmidt U; Lippert H
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in patients with carcinoma of the papilla of Vater.
    Tanaka S; Hirohashi K; Tanaka H; Yamamoto T; Kubo S; Shuto T; Takemura S; Kinoshita H
    Hepatogastroenterology; 2002; 49(46):1116-9. PubMed ID: 12143216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perineural Invasion is a Strong Prognostic Factor in Colorectal Cancer: A Systematic Review.
    Knijn N; Mogk SC; Teerenstra S; Simmer F; Nagtegaal ID
    Am J Surg Pathol; 2016 Jan; 40(1):103-12. PubMed ID: 26426380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of tumor size on survival of patients with resected pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.
    Li D; Hu B; Zhou Y; Wan T; Si X
    BMC Cancer; 2018 Oct; 18(1):985. PubMed ID: 30326871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of recurrence pattern after resection for pancreatic cancer.
    Tanaka M; Mihaljevic AL; Probst P; Heckler M; Klaiber U; Heger U; Büchler MW; Hackert T
    Br J Surg; 2019 Nov; 106(12):1590-1601. PubMed ID: 31454073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological features related to survival in adenocarcinoma of the Vaterian system in a Mexican population.
    Herrera-Goepfert R; Soca-Chafre G; Almeida-Navarro S; Montiel-Dávalos A
    Hum Pathol; 2019 Jan; 83():68-76. PubMed ID: 30179685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.
    Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG
    J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraductal dissemination of papillary adenocarcinoma of the ampulla of Vater in the pancreatic duct.
    Matsubara A; Nara S; Sekine S; Ojima H; Kosuge T; Shimada K; Kushima R; Kanai Y; Hiraoka N
    Pathol Int; 2014 Jan; 64(1):39-44. PubMed ID: 24471969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Predictors of recurrence after pancreaticoduodenectomy for carcinoma of the ampulla of Vater].
    Chen J; Cai S; Dong J
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1242-4. PubMed ID: 22985555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas.
    Åkerberg D; Ansari D; Andersson R
    World J Gastroenterol; 2016 Jul; 22(28):6424-33. PubMed ID: 27605878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene Expression of Col11A1 Is a Marker Not only for Pancreas Carcinoma But also for Adenocarcinoma of the Papilla of Vater, Discriminating Between Carcinoma and Chronic Pancreatitis.
    Kleinert R; Prenzel K; Stoecklein N; Alakus H; Bollschweiler E; Hölscher A; Warnecke-Eberz U
    Anticancer Res; 2015 Nov; 35(11):6153-8. PubMed ID: 26504042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection.
    Ozaki H; Hiraoka T; Mizumoto R; Matsuno S; Matsumoto Y; Nakayama T; Tsunoda T; Suzuki T; Monden M; Saitoh Y; Yamauchi H; Ogata Y
    Surg Today; 1999; 29(1):16-22. PubMed ID: 9934826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphometric microvascular characteristics in the prognosis of pancreatic and ampullary carcinoma.
    Giannopoulos G; Kavantzas N; Parasi A; Tiniakos D; Peros G; Tzanakis N; Patsouris E; Pavlakis K
    Pancreas; 2007 Jul; 35(1):47-52. PubMed ID: 17575545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Artemin and GFRalpha3 expressions and their relevance to perineural invasiveness and metastasis of pancreatic carcinoma].
    Zhu DL; Luo DL; Luo G; Wang B; Gao JM
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):428-32. PubMed ID: 19304517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synuclein-gamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer.
    Hibi T; Mori T; Fukuma M; Yamazaki K; Hashiguchi A; Yamada T; Tanabe M; Aiura K; Kawakami T; Ogiwara A; Kosuge T; Kitajima M; Kitagawa Y; Sakamoto M
    Clin Cancer Res; 2009 Apr; 15(8):2864-71. PubMed ID: 19351749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.